Catechol- O -Methyl Transferase (COMT) Inhibitors in Patients with Parkinson's Disease: Is COMT Genotype a Useful Indicator of Clinical Efficacy?

Author： Rinne J.O.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.3, Iss.1, 2003-01, pp. : 11-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Catechol-O-Methyl Transferase (COMT) Inhibitors for Schizophrenia:An Approach to Target Validation and Rational Drug Design

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 246-252

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacology, Therapeutic Use and Potential of COMT Inhibitors in Parkinson’s Disease

By Kaakkola S.  

Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. : 1233-1250

Adis International

Access to resources Recommend Favorite

Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 251-263

Bentham Science Publishers

Access to resources Recommend Favorite

Can COMT Inhibitors Improve Cognitive Functions in Patients with Parkinson's Disease?

By Meco G.   Alessandri A.  

CNS Drugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 227-232

Adis International

Access to resources Recommend Favorite

Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers

By Guo Song   Chen Da   Zhou Dong   Sun Hong   Wu Gui   Haile Colin   Kosten Therese   Kosten Thomas   Zhang Xiang  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 449-456

Springer Publishing Company

Access to resources Recommend Favorite